Prince Pharmaceutical Co., Ltd. (TPEX:6935)
Taiwan · Delayed Price · Currency is TWD 28.50
+0.05 (0.18%)
Mar 6, 2026, 11:08 AM CST
Prince Pharmaceutical Market Cap
Prince Pharmaceutical has a market cap or net worth of 1.04 billion as of March 5, 2026. Its market cap has increased by 20.04% in one year.
Market Cap
1.04B
Enterprise Value
1.41B
Revenue
798.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.50
Market Cap Chart
Since March 29, 2023, Prince Pharmaceutical's market cap has decreased from 1.94B to 1.04B, a decrease of -46.42%. That is a compound annual growth rate of -19.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 1.04B | -8.52% |
| Dec 31, 2025 | 1.14B | 42.01% |
| Dec 31, 2024 | 801.65M | -36.72% |
| Dec 29, 2023 | 1.27B | -34.82% |
| Mar 29, 2023 | 1.94B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeneFerm Biotechnology | 1.71B |
| InnoPharmax | 1.67B |
| Tien Liang BioTech | 1.64B |
| Winston Medical Supply | 1.50B |
| DV Biomed | 1.34B |
| Excelsior Biopharma | 1.27B |
| Anxo Pharmaceutical | 1.17B |
| Mediera | 1.14B |